Version 1
: Received: 9 May 2020 / Approved: 11 May 2020 / Online: 11 May 2020 (10:10:42 CEST)
How to cite:
Pratama, B. A.; Rachman, A. M.; Anggraeni, V. Y.; Maharani, E.; Trisnawati, I.; Riyanto, B. S.; Hartopo, A. B. Deteriorating Atrioventricular Block in COVID-19 Suspected Patient after Receiving Initial Dose of Azythromycin and Hydroxychloroquine. Preprints2020, 2020050190. https://doi.org/10.20944/preprints202005.0190.v1
Pratama, B. A.; Rachman, A. M.; Anggraeni, V. Y.; Maharani, E.; Trisnawati, I.; Riyanto, B. S.; Hartopo, A. B. Deteriorating Atrioventricular Block in COVID-19 Suspected Patient after Receiving Initial Dose of Azythromycin and Hydroxychloroquine. Preprints 2020, 2020050190. https://doi.org/10.20944/preprints202005.0190.v1
Pratama, B. A.; Rachman, A. M.; Anggraeni, V. Y.; Maharani, E.; Trisnawati, I.; Riyanto, B. S.; Hartopo, A. B. Deteriorating Atrioventricular Block in COVID-19 Suspected Patient after Receiving Initial Dose of Azythromycin and Hydroxychloroquine. Preprints2020, 2020050190. https://doi.org/10.20944/preprints202005.0190.v1
APA Style
Pratama, B. A., Rachman, A. M., Anggraeni, V. Y., Maharani, E., Trisnawati, I., Riyanto, B. S., & Hartopo, A. B. (2020). Deteriorating Atrioventricular Block in COVID-19 Suspected Patient after Receiving Initial Dose of Azythromycin and Hydroxychloroquine. Preprints. https://doi.org/10.20944/preprints202005.0190.v1
Chicago/Turabian Style
Pratama, B. A., Bambang Sigit Riyanto and Anggoro Budi Hartopo. 2020 "Deteriorating Atrioventricular Block in COVID-19 Suspected Patient after Receiving Initial Dose of Azythromycin and Hydroxychloroquine" Preprints. https://doi.org/10.20944/preprints202005.0190.v1
Abstract
Coronavirus 2019 (COVID-19) is an infectious disease that is becoming a pandemic. Hydroxychloroquine in combination with azythromycin are among drugs currently in use to eradicate COVID-19. Despite concerns due to its potential cardiac toxicity, hydroxychloroquine is widely accepted in mild and moderate COVID-19 pneumonia. In this case report, we report a case of a young Indonesian adult male with suspected COVID-19 pneumonia who received hydroxychloroquine and azythromycin therapies and during 24 hour experienced deterioration of atrioventricular block.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.